Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SilverSeal
- Development stage
- Unknown
- Lead developer
- NexGel
- Administration
- Topical
01
Overview
SilverSeal is a topical hydrogel wound dressing designed for the management of various wound types, including minor cuts, scrapes, first and second-degree burns, and dermal ulcers. Developed by NEXGEL (formerly Alliqua), the dressing utilizes electron-beam cross-linking technology to create a moist wound environment conducive to healing. It incorporates silver-coated fibers that provide antimicrobial properties, protecting the wound from infection. As a medical device with FDA 510(k) clearance, it is used to promote the healing of skin ulcers and superficial wounds while maintaining a protective barrier.
- Brand names
- SilverSeal
Beyond the preview
Go deeper on SilverSeal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SilverSeal.